Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
BMJ Quality & Safety
|
September 21, 2023
CheckPOINT: a simple tool to measure Surgical Safety Checklist implementation fidelity
Rachel Moyal-Smith, James C Etheridge, Nathan Turley, et al.
Birth (Berkeley, Calif.)
|
March 2, 2022
Improving communication and teamwork during labor: A feasibility, acceptability, and safety study
Amber Weiseth, Avery Plough, Reena Aggarwal, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
June 24, 2024
Adapting the World Health Organization's Surgical Safety Checklist to High-Income Settings: A Hybrid Effectiveness-Implementation Trial Protocol
Nathan Turley, Karolina Kogut, Barbara Burian, et al.
The British Journal of Dermatology
|
December 9, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma
Peinan Zhao, Christopher Chew, Pacman Szeto, et al.
The Prostate
|
February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America
Anthony M Joshua, Neal D Shore, Fred Saad, et al.
Investigational New Drugs
|
February 1, 2008
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
Thomas E Hutson, Svetislava Vukelja, Daniel Atienza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
BMJ Quality & Safety
|
September 21, 2023
CheckPOINT: a simple tool to measure Surgical Safety Checklist implementation fidelity
Rachel Moyal-Smith, James C Etheridge, Nathan Turley, et al.
Birth (Berkeley, Calif.)
|
March 2, 2022
Improving communication and teamwork during labor: A feasibility, acceptability, and safety study
Amber Weiseth, Avery Plough, Reena Aggarwal, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
June 24, 2024
Adapting the World Health Organization's Surgical Safety Checklist to High-Income Settings: A Hybrid Effectiveness-Implementation Trial Protocol
Nathan Turley, Karolina Kogut, Barbara Burian, et al.
The British Journal of Dermatology
|
December 9, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma
Peinan Zhao, Christopher Chew, Pacman Szeto, et al.
The Prostate
|
February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America
Anthony M Joshua, Neal D Shore, Fred Saad, et al.
Investigational New Drugs
|
February 1, 2008
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
Thomas E Hutson, Svetislava Vukelja, Daniel Atienza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Page
of 4